Fate Therapeutics FATE
NASDAQ FATE
$2.09 +0.02 (+0.97%)
At close: Oct 22, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Short-term Investments (2016 - 2026)

Updated

Fate Therapeutics' Short-term Investments was $121.34 million in Q2 2026, down 33.2% from $181.58 million a year earlier and down 10.3% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Short-term Investments (2016 - 2026) Analysis & Trends

At the end of FY2025, Short-term Investments at Fate Therapeutics came in at $157.03 million, down 35.4% from FY2024.

  • Short-term Investments has now declined for four consecutive years, with a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
  • In earlier years, Short-term Investments was $243.01 million in FY2024 (-11.1%), $273.31 million in FY2023 (-27.1%), $374.89 million in FY2022 (-22.3%) and $482.33 million in FY2021 (+52.8%).
  • The Q2 2026 figure marks the lowest quarterly Short-term Investments since Q2 2020.
  • Compared with a year earlier, Short-term Investments has declined for 18 straight quarters, with an average decline of 27.3% over the last eight quarters.
  • The best year-over-year quarter for Short-term Investments over five years was Q3 2021 (growth of 293.4%); the worst was Q2 2023 (a decline of 35.5%).
  • Per Business Quant data, FATE's Short-term Investments in the three quarters before Q2 2026 was $135.25 million (Q1 2026), $157.03 million (Q4 2025) and $174.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Fate Therapeutics 251.03 Mn 97.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.34 Mn
Mar 31, 2026 135.25 Mn
Dec 31, 2025 157.03 Mn
Sep 30, 2025 174.80 Mn
Jun 30, 2025 181.58 Mn
Mar 31, 2025 195.51 Mn
Dec 31, 2024 243.01 Mn
Sep 30, 2024 259.01 Mn
Jun 30, 2024 267.96 Mn
Mar 31, 2024 262.22 Mn
Dec 31, 2023 273.31 Mn
Sep 30, 2023 316.40 Mn
Jun 30, 2023 331.13 Mn
Mar 31, 2023 366.88 Mn
Dec 31, 2022 374.89 Mn
Sep 30, 2022 423.04 Mn
Jun 30, 2022 513.58 Mn
Mar 31, 2022 509.03 Mn
Dec 31, 2021 482.33 Mn
Sep 30, 2021 549.52 Mn
API Access

Fate Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY